J

Jodha Tishon | Toronto, Canada

Research site

(Unclaimed)

Location

1033 Bay Street, Toronto, Ontario, Canada

Site insights

Top conditions

Top treatments

Daridorexant

TAK-994

ACT-541468

E2086

Atomoxetine

FT218

Solriamfetol

Aripiprazole

Vortioxetine

Aroxybutynin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1

The primary purpose of this study is to evaluate the efficacy of single oral doses of E2086 compared to placebo in the treatment of excessive daytime...

Enrolling

Narcolepsy Type 1 (NT1)

Drug: Active Comparator Placebo

Drug: E2086 Placebo

Locations recently updated

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine